جست‌وجوی استاد و پژوهشگر

Tomiko Yonedaمشاهده پروفایل

استادیار

• Gerontology
• Personality Psychology
• Health Psychology
• +۳ مورد دیگر

Tomiko Yoneda is an Assistant Professor in the Department of Psychology at the University of California, Davis. Her research focuses on understanding how personality traits, social relationships, and lifestyle factors influence health and cognitive outcomes in older adults. She employs interdisciplinary methods, including longitudinal studies and coordinated data analyses, to explore topics like personality-cognition links, social determinants of health, and aging disparities. Dr. Yoneda is also committed to fostering inclusive academic environments and mentoring students from diverse backgrounds. Her work spans multiple domains: (1) Personality dynamics in aging, examining traits like neuroticism and conscientiousness as predictors of health and longevity; (2) Social relationships' impact on physiological health (e.g., cortisol regulation in couples); and (3) Cross-cultural studies of aging in Japan and North America. Notable contributions include systematic reviews on personality-allostatic load relationships and meta-analyses linking personality to mortality risks. Received EDITOR'S CHOICE recognition in Psychoneuroendocrinology (2024) and Journal of Personality and Social Psychology (2022) Principal investigator of the Yoneda Lab at UC Davis Dr. Yoneda emphasizes translational research that bridges psychological and biomedical perspectives. She collaborates internationally on projects analyzing cognitive healthspan, dementia risk factors, and interventions to promote healthy aging. Her teaching focuses on lifespan development and research methodologies.

Jesse J. Heltonمشاهده پروفایل

دانشیار

• Child Maltreatment
• Adverse Childhood Experiences
• Food Insecurity
• +۳ مورد دیگر

Jesse J. Helton, Ph.D., is an Associate Professor in the School of Social Work at Saint Louis University, where he has been since 2014. His research focuses on child maltreatment, adverse childhood experiences (ACEs), food insecurity, and disability, with notable work published in JAMA Pediatrics , Child Maltreatment , and Preventative Medicine . He holds editorial roles at the Child Maltreatment journal and serves on the Prevention Committee of the American Professional Society on the Abuse of Children. Dr. Helton’s community partnerships address child abuse prevention, food security, and family violence mitigation in collaboration with statewide and local organizations. Education: Ph.D. in Social Work, University of Illinois; M.A. in Social Work, University of New Hampshire. Research Interests: Dr. Helton’s work explores intersections between childhood trauma, socioeconomic factors, and health outcomes. Key themes include the impact of food insecurity on caregiver-child dynamics, disparities in ACEs among marginalized groups, and policy interventions to reduce maltreatment. His studies often employ mixed-methods approaches, combining quantitative data analysis with qualitative insights from affected communities. Awards: Recipient of the 2020 Association of Jesuit Colleges Leadership Institute award, 2018 Outstanding Young Alumni from Eureka College, and a 2014 Innovative Teaching Fellowship from SLU’s Reinert Center. Teaching: Courses include Principles of Statistics and Data Analysis , Research Methods for Diverse Societies , and Science of Helping . He emphasizes evidence-based practices and culturally responsive pedagogy. Labs/Teams: Collaborates with multidisciplinary teams across universities and NGOs, focusing on translational research to inform child welfare policies and community programs.

• Clinical exercise physiology
• Medical and health aspects of master athletes
• Prevention and rehabilitation of chronic disease
• +۶ مورد دیگر

Mike Climstein serves as a Lecturer in Human Sciences within the Faculty of Health at Southern Cross University (SCU), where he coordinates the Master of Clinical Exercise Physiology program and acts as Deputy Academic Integrity Officer. He concurrently holds an adjunct Associate Professor position in the Physical Activity, Lifestyle, Ageing and Well-being Research Group at the University of Sydney and directs SCU's Aquatic Based Research initiative. His academic credentials include a PhD in Exercise Science & Human Performance from Oregon State University (1990), an MSc in Exercise Science from Utah State University (1986), and a BSc in Biology from Utah State University (1982). Climstein's research spans clinical exercise physiology with emphases on master athletes' health, chronic disease rehabilitation, sports injury surveillance (particularly surfing), cardiac rehabilitation, smart textile monitoring, and osteoporosis. His work integrates technology-driven health solutions with population-specific exercise interventions, notably for aging populations and athletes. Analysis of his recent publications reveals three dominant trends: 1) AI applications in dermatological diagnostics (e.g., melanoma detection systems), 2) physiological adaptations in aging populations through martial arts and aquatic exercise, and 3) epidemiological studies of chronic conditions in master athletes and occupational groups. These reflect his dual focus on technological innovation and practical health interventions. His scientific recognition includes: Fellowship by Sports Medicine Australia (FASMF) Fellowship by American College of Sports Medicine (FACSM) Fellowship by Exercise and Sports Science Australia (FAAESS) Climstein actively supervises 4 PhD and 2 Master's students while co-supervising 6 Doctor of Physiotherapy candidates. His research program is supported by 38 grants totaling over $7.8 million AUD, including studies on aquatic rehabilitation and smart textile monitoring. As Director of Aquatic Based Research, he leads interdisciplinary teams investigating water-based exercise interventions for chronic disease management, with ongoing projects in cardiac rehabilitation and osteoporosis prevention.

• Social Inequality
• Public Health
• Global Health
• +۱۲ مورد دیگر

Terje Andreas Eikemo is a Professor at the Department of Sociology and Political Science , Norwegian University of Science and Technology (NTNU) , and Head of the CHAIN research center . His work focuses on the intersection of social inequality , public health , and global policy , emphasizing how socioeconomic factors like education , income , and welfare systems influence mortality , chronic diseases , and mental health . He combines theories from sociology , epidemiology , and medicine to address health disparities across diverse contexts, including pandemics , climate change , and migration . 2009: Prize for Young Researchers in the Humanities 2010: SINTEF Prize for Outstanding Research 2014: NTNU Star Program Eikemo has published extensively in top journals like The Lancet and BMJ Open , with research themes spanning social determinants of health , policy interventions , and global health equity . His work includes GBD studies , European Social Survey analyses , and refugee health assessments. He serves as Editor-in-Chief of the Scandinavian Journal of Public Health and collaborates with international bodies like WHO and UNESCO .

David Walkerمشاهده پروفایل

استاد

• Aging
• Mitochondrial Biology
• Neurodegeneration
• +۳ مورد دیگر

David Walker is a Professor and Vice Chair of Academic Personnel in the Department of Integrative Biology and Physiology at the University of California, Los Angeles. He leads a research lab focused on understanding the molecular and cellular basis of aging, utilizing Drosophila melanogaster to investigate mechanisms such as mitochondrial dysfunction, autophagy, and intestinal barrier integrity. His work aims to identify therapeutic targets for age-related diseases. Education: B.S., Genetics, Queen's University Belfast (1995) MRes, Molecular Biology, University of Manchester (1996) Ph.D., Genetics, University of Manchester (2000) Walker's research interests center on the biological processes driving aging, with emphasis on mitochondrial dynamics, neurodegeneration, and gut-microbiota interactions. His lab employs genetic, molecular, and physiological approaches in Drosophila to dissect how cellular deterioration impacts lifespan and healthspan, bridging insights to human aging pathologies. Key themes include the role of autophagy adaptors (e.g., p62/SQSTM1), mitochondrial fission, and intestinal homeostasis in longevity. His recent publications (2014–2024) reveal a consistent focus on brain aging, mitophagy, and gut-brain axis disruptions, with trends toward identifying midlife interventions for healthspan extension. Articles frequently integrate cellular stress responses, metabolic regulation, and neurodegeneration, highlighting Drosophila as a versatile model for translational aging research. No scientific awards, prizes, or fellowships are mentioned in the provided text. While specific grants or student advisees are not detailed, Walker's lab actively mentors researchers and contributes to collaborative projects on aging mechanisms. Future directions may involve exploring mitochondrial-immune interactions and novel longevity pathways. Walker directs a Drosophila-focused laboratory at UCLA, emphasizing genetic screens and mechanistic studies to uncover evolutionarily conserved aging pathways. The team investigates tissue-specific aging cascades, including neuronal and intestinal systems, to develop strategies for mitigating age-related decline.

Markus Riesslandمشاهده پروفایل

استادیار

• Cellular Senescence
• Neurodegenerative Diseases
• Parkinson's Disease
• +۳ مورد دیگر

Markus Riessland is an Assistant Professor at Stony Brook University’s Renaissance School of Medicine, part of the Empire Innovation Program focused on the Aging Brain. He holds a PhD from the University of Cologne, Germany, specializing in molecular biology, neuroscience, and neurodegenerative diseases. His research centers on cellular senescence in neurons, particularly post-mitotic dopaminergic neurons linked to Parkinson’s disease. He discovered that these neurons can undergo senescence, a process typically absent in non-dividing cells, which has implications for aging and neurodegeneration. Dr. Riessland’s lab employs stem cell models, mouse studies, and advanced sequencing techniques (TRAP-seq, RNA-seq) to investigate senescence mechanisms, identify genetic modifiers influencing neuronal vulnerability, and explore therapies to counteract senescence-driven pathology. His work bridges molecular biology and clinical implications, emphasizing translational approaches for age-related diseases. Notable achievements include an F1000 Exceptional Rating for his 2017 Cell Stem Cell paper and an AJHG Editor’s Corner Highlight for his ribosome profiling study. His research has led to insights on SATB1’s role in senescence, lipid-driven senescence in dopaminergic neurons, and midbrain inflammation in Parkinson’s. Collaborative efforts span international projects on SMA and neuroprotective modifiers like Neurocalcin Delta. While no students are listed here, his work impacts therapeutic development in neurodegenerative diseases through senolytic strategies and genetic interventions. Education: PhD in Molecular Biology from University of Cologne, Germany. Awards: F1000 Exceptional Rating (2017), AJHG Editor’s Corner Highlight (2017). Labs/Teams: Leads research on neuronal senescence mechanisms and therapeutic targets, integrating stem cell biology and systems biology approaches.

• Biological Aging
• Cancer Survivorship
• Sleep Science
• +۵ مورد دیگر

Judith E Carroll, PhD, is an Adjunct Associate Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA's School of Medicine, where she holds the George F. Solomon Professorship of Psychobiology. She directs the Aging Biology & Behavior Lab and co-leads the Infrastructure for Research in Equity, Aging, Cancer and Health initiative. Her research bridges psychoneuroimmunology, geroscience, and oncology, with continuous NIH funding since 2013. Education: PhD in Biological & Health Psychology, University of Pittsburgh (2010) MA in Biopsychology & Aging, Sonoma State University (2003) BA in Psychology, Sonoma State University (2002) Her research examines biological mechanisms linking stress, sleep, and aging in cancer populations. Primary interests include: Accelerated aging biomarkers in breast cancer survivors Sleep health interventions to reverse cellular aging Impact of early-life adversity on lifelong health trajectories Social determinants of cognitive decline in oncology Recent publications (2023-2025) demonstrate: Dominant focus on epigenetic aging and inflammation in oncology Longitudinal studies of cancer-related cognitive decline Methodological innovation in transcriptomic biomarker discovery Health disparities framework across 80% of publications Awards: American Psychosomatic Society Young Scholar Award (2012) American Sleep Medicine Foundation Bridge to K Award (2013) American Cancer Society Research Scholar Award (2015) STOP CANCER Career Development Award (2016) PNIRS Robert Ader New Investigator Award (2019) Active Grants (NIH): R01AG082348: Patterns of Biological Aging in Cancer Survivors (MPI, 2023-2028) R56AG068086: Heterogeneity in Aging Among Breast Cancer Survivors (PI, 2021-2022) R01CA237535: Accelerated Aging in Breast Cancer (PI, 2020-2023) She mentors through the TLC (Thinking and Living with Cancer) Study consortium involving 15+ institutions. Leads the Aging Biology & Behavior Lab researching stress-sleep-aging mechanisms and co-directs the Infrastructure for Research in Equity, Aging, Cancer and Health (REACH) initiative, fostering multi-institutional collaborations on health disparities.

Andreas Beyerمشاهده پروفایل

استاد

• Aging Research
• Proteomics
• Systems Biology
• +۵ مورد دیگر

Prof. Dr. Andreas Beyer holds a faculty position at the University of Cologne, affiliated with the Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and the Cologne Excellence Cluster for Cellular Mechanisms in Cancer (CMMC). His research focuses on systems-level analysis of aging processes in humans and model organisms, integrating genomic, proteomic, and computational approaches. Key interests include understanding how genetic variation influences protein networks, developing algorithms for big data analysis, and exploring epigenetic mechanisms related to longevity. Research projects include studying age-associated changes in transcriptional elongation, molecular networks in kidney disease, and the impact of dietary restriction on aging. His group develops tools for proteomics and systems biology, such as methods for analyzing limited proteolysis data and single-cell resolution imaging. Collaborative efforts emphasize translational research in aging-related diseases and drug discovery. Prof. Beyer’s work spans computational biology, molecular genetics, and translational medicine. Notable contributions include identifying epigenetic changes linked to longevity and developing predictive models for age-related disease progression. His lab’s projects often involve multi-omics integration and network-based analyses to uncover disease mechanisms. His research has implications for personalized medicine, cancer biology, and interventions to extend healthspan. Current efforts include optimizing drug combinations targeting aging processes and advancing proteomic technologies for clinical applications.

Shahaf Pelegمشاهده پروفایل

پژوهشگر

• Aging Biology
• Epigenetics
• Metabolic Regulation
• +۷ مورد دیگر

Dr. Shahaf Peleg is the Head of the Energy Metabolism and Epigenetics Working Group at the Research Institute for Farm Animal Biology (FBN). His research focuses on aging biology, epigenetic mechanisms, and metabolic interventions. Key areas include histone acetylation regulation, mitochondrial function, and dietary effects on longevity. He uses models like Drosophila, C. elegans, and mice (e.g., Titan mouse) to study aging pathways. Leading interdisciplinary projects on energy metabolism and epigenetic interactions. Developing optogenetic tools for mitochondrial research. Expertise in lipidomics and circadian metabolism. Recent work emphasizes dietary interventions in obesity-related aging and optogenetic rejuvenation of cellular energetics. Active in collaborative networks like ARDD Emerging Science workshops. Publications span metabolic pathway analysis, alcohol's epigenetic impacts, and longevity biomarkers. His team's Titan mouse model is a key tool for testing frailty attenuation strategies.

Coleen T. Murphyمشاهده پروفایل

استاد

• Aging
• Molecular Biology
• Genetics & Genomics
• +۷ مورد دیگر

Coleen T. Murphy is the James A. Elkins Jr. Professor in the Life Sciences and Professor of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics at Princeton University. She serves as Director of the Lewis-Sigler Institute and Director of the Paul F. Glenn Laboratories for Aging Research, highlighting her leadership in aging and genomics research. Her work bridges molecular biology, genetics, and computational approaches to understand aging and age-related decline. Her research focuses on the molecular mechanisms of aging, particularly using the nematode C. elegans as a model organism. Key interests include longevity pathways, insulin/IGF-1 signaling, reproductive aging, neurodegenerative diseases, transgenerational inheritance, and mitochondrial function. Her lab integrates genomic, transcriptomic, and functional screening techniques to identify genes and pathways that regulate aging and healthspan. The recent publications of her lab demonstrate a strong trend in interdisciplinary research combining genetics, neuroscience, and computational biology. Themes include cognitive aging, learned behavior, pathogen avoidance, metabolic regulation, and drug discovery in neurodegenerative models. Her work increasingly employs high-throughput methods and cross-omics analysis to uncover conserved mechanisms relevant to human health. HHMI Faculty Scholar, Howard Hughes Medical Institute (2016) Pioneer Award, National Institutes of Health (2015) Innovation Award, Department of Molecular Biology, Princeton University (2014) Glenn Foundation for Medical Research Award (2012) Dr. Murphy leads a vibrant research group and mentors numerous students and postdoctoral researchers. Her lab has secured significant funding from HHMI, NIH, and the Glenn Foundation, supporting innovative projects in aging and longevity. She also directs major research initiatives, including the Simons Foundation’s SCPAB (Plasticity and the Aging Brain), underscoring her national leadership. The Murphy Lab at Princeton is a multidisciplinary team employing C. elegans to study aging, cognitive decline, and intergenerational signaling. The lab utilizes cutting-edge tools including microfluidics (e.g., CeLab), transcriptomics, and behavioral assays. It is part of the Department of Molecular Biology and the Lewis-Sigler Institute, fostering collaboration across genomics, neuroscience, and computational biology.

Sheng Liمشاهده پروفایل

دانشیار

• Cancer Epigenetics
• Aging
• Clonal Hematopoiesis
• +۳ مورد دیگر

Sheng Li is an Associate Professor of Cancer Biology at the University of Southern California's Keck School of Medicine. She co-leads the Epigenetic Regulation in Cancer Program at the Norris Comprehensive Cancer Center. Her research integrates multi-omics and computational approaches to study epigenetic heterogeneity in blood cancers, aging, and clonal hematopoiesis. Her lab focuses on single-cell spatial multi-omics, 3D epigenomics, and long-read sequencing to map epigenetic drivers of leukemogenesis. Awards include the Leukemia & Lymphoma Society Scholar Award and AACR NextGen Star recognition. She mentors PhD students and postdocs, with her team publishing extensively in high-impact journals. Her publications demonstrate a strong emphasis on computational epigenetics, cancer systems biology, and geroscience. Recent work includes developing tools for spatial transcriptomics interpretation and modeling IDH-mutant AML gene networks.

• Biomarkers
• Epigenetics
• Aging
• +۳ مورد دیگر

Brian Chen is an Assistant Adjunct Professor at the Herbert Wertheim School of Public Health & Human Longevity Science at the University of California San Diego (UCSD). His research focuses on biomarkers of aging, epigenetics, and epidemiological studies , with a particular interest in translating these findings into clinical applications and population health strategies. Education: PhD in Epidemiology, University of California Los Angeles (UCLA) MPH in Epidemiology/Biostatistics, University of California Berkeley Bachelor of Science in Biochemistry/Cell Biology & Psychology, UC San Diego Research Interests: Brian's work centers on understanding biological aging mechanisms through epigenetic changes, particularly DNA methylation patterns. He explores how these biomarkers correlate with age-related diseases (e.g., dementia, cardiovascular disease) and health disparities. His studies often involve large-scale epidemiological cohorts and cutting-edge genomic technologies. Publications: His recent work emphasizes validation of aging biomarkers, epigenetic clock analyses, and translational strategies for clinical implementation. Key contributions include studies on racial/ethnic health disparities linked to epigenetic aging and the role of biomarkers in predicting cardiovascular outcomes. Collaborations: Brian frequently collaborates with leading researchers like Steve Horvath (epigenetic clock pioneer), Luigi Ferrucci (aging epidemiology), and Tamara B. Horvath (neuroendocrinology). His work has been cited over 5,000 times in high-impact journals. Future Directions: Current projects include developing multi-omic aging biomarker panels and investigating interventions to modulate epigenetic aging processes. He also advocates for standardized validation frameworks for aging biomarkers in clinical settings.

Richard A. Millerمشاهده پروفایل

استاد

• Aging
• Biology of Aging
• Cellular Stress Resistance
• +۳ مورد دیگر

Richard A. Miller serves as Professor of Pathology at the University of Michigan and Director of the Paul Glenn Center for Biology of Aging, based in the BSRB building (3001 BSRB) at the University of Michigan Medical School campus in Ann Arbor. His research program focuses on: Drugs that slow aging in mice (Intervention Testing Program) Long-lived mutant mouse models Cross-species comparative biology of aging Cellular stress resistance mechanisms Biomarkers and genetics of aging Miller leads the Miller Lab, which maintains active research on pharmacological interventions in aging, evolutionary aspects of longevity, and stress response pathways. The lab collaborates with the NIA-funded Intervention Testing Program and produces foundational work in aging biology, including hard-to-find essays on aging biomarkers. His team investigates how cellular stress resistance pathways influence lifespan across species, with implications for extending healthspan in mammals.

Codruta Igneaمشاهده پروفایل

استادیار

• Synthetic Biology
• Metabolic Engineering
• Engineering of Biological Membranes
• +۳ مورد دیگر

Codruta Ignea is an Assistant Professor in the Department of Bioengineering at McGill University , Montreal, Canada. Her research focuses on synthetic biology and metabolic engineering, specifically reconstructing biosynthetic pathways in microbial chassis for high-value compound production. Areas of Expertise : Synthetic Biology, Metabolic Engineering, Biological Membrane Engineering Contact : codruta.ignea@mcgill.ca , McConnell Engineering Building, 817 Sherbrooke Street West, Montreal, QC H3A 0C3 Her work involves designing synthetic biosystems that bio-mimic producer organism environments to enhance bioprocess performance, discovering novel enzymatic activities, and expanding natural chemical diversity for drug discovery. Key applications include pharmaceutical production and new-to-nature molecules with improved bioactivities. Recent publications highlight her contributions to yeast engineering for terpenoid biosynthesis, pathway optimization, and artificial intelligence integration in synthetic biology. Her team has developed systems for producing anti-cancer, anti-viral, and anti-inflammatory compounds through microbial platform innovation.

Sofiya Milmanمشاهده پروفایل

استاد

• Longevity Research
• Aging Mechanisms
• Endocrinology
• +۳ مورد دیگر

Sofiya Milman, M.D., M.S., is a Professor in the Departments of Medicine (Endocrinology) and Genetics at Albert Einstein College of Medicine. She serves as Interim Vice Chair for Research in the Department of Medicine and Director of Human Longevity Studies at Einstein’s Institute for Aging Research. Her research focuses on genomic mechanisms underlying healthy aging, particularly in centenarian populations. Dr. Milman’s work emphasizes the role of hormonal pathways, especially the somatotropic axis involving IGF-1, in regulating longevity and age-related diseases. Her studies demonstrate that lower IGF-1 levels correlate with extended survival and cognitive health in individuals with exceptional longevity. Research interests include translational studies on longevity genes, protective endocrine parameters, and interventions to combat age-related diseases. Her work integrates genetic data with phenotypic information from longevity families to uncover molecular mechanisms driving healthspan extension. Key findings include the antagonistic pleiotropy of IGF-1, where lower IGF-1 levels may protect against cardiovascular disease and diabetes while promoting longevity. Dr. Milman’s articles span topics like IGF binding proteins’ mortality prediction, proteomic changes across lifespan, and genetic insights into extreme longevity. Grants supporting her research include NIH grants (R01 AG057909, R01 AG044829) focused on aging mechanisms. She collaborates widely, with co-authors such as Nir Barzilai and Aviv Bergman. Her lab is part of the Institute for Aging Research, dedicated to translating basic discoveries into clinical interventions for healthy aging.